Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017 Bay Area's Carmot Lands $240M+ R&D Tie-Up With Biotech Giant Amgen December 5, 2017 Former Sarepta CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator May 17, 2017
Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017
Former Sarepta CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator May 17, 2017